Varian GammaMedplus iX HDR Brachytherapy from Japan
Remote afterloading system for high-dose rate brachytherapy using Iridium-192 sources in cancer treatment. Designed for nonprofit radiation oncology departments. Qualifies under HTS 9810.00.80.00 for therapeutic apparatus with integral radioactive delivery.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Submit detailed source exchange mechanism specifications and safety interlocks
• Include treatment planning software validation for institutional protocols
• Verify compliance with 10 CFR Part 35 therapeutic use requirements